Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05204732
Other study ID # B6702021001262
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 30, 2022
Est. completion date October 26, 2026

Study information

Verified date September 2023
Source University Ghent
Contact Tine Papeleu
Phone 0471725172
Email tine.papeleu@ugent.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this project is to investigate the short- and the longer-term effect of intonation training on vocal characteristics, listener perceptions and patient related outcome measures (PROMS) in gender diverse people using a randomized sham-controlled trial.


Description:

Background and Problem Statement. Speech training in gender diverse individuals focuses on aspects of communication that strongly influence gender perception. Findings from the literature suggest that a listener's gender perception is determined not only by pitch, but also by other components such as intonation. However, the nature and extent of pitch changes required to alter gender perception are not known. In speech therapy, intonation training is frequently used for speech feminization. However, empirical evidence for this is lacking. Research questions and/or hypotheses Thisresearch investigates the short- and long-term effects of intonation training on acoustic voice characteristics, gender perception and findings of gender-diverse individuals using a randomized sham-controlled trial (RCT). Based on findings from the literature, (a) gender-congruent values are expected for intonation parameters, in addition (b) assessments of gender that fit the gender identity of the person and (c) an improvement in self-assessment after intonation training in the short and long term. This study will lead to new insights into the relationship between intonation and gender perception and makes an important contribution to the evidence for the use of intonation training. Research Protocol An RCT will be used. Gender diverse individuals will be recruited through the Ghent University Hospital. Inclusion criteria are: diagnosis of gender dysphoria established by the multidisciplinary gender team, age between 18 and 60 years, normal hearing and Dutch mother tongue. Taking into account the expertise of the research group and the low-threshold recruitment through the gender clinic of UZ Gent, a total of n=20 participants is a very feasible number. Subjects will be randomly assigned to the experimental (intonation training) or control group (receiving a placebo intervention). Randomization will be stratified by age group and baseline speaking fundamental frequency. The experimental group will receive 4 weeks (1h/week) of intonation training with a pre- and post-voice assessment and a follow-up assessment after 8 weeks. The control group will receive sham therapy at a similar duration and frequency, also with a pre- and post-measurement and a follow-up assessment after 8 weeks. The control group will receive 4 more weeks (1 hour/week) of intonation training with a post measurement (due to ethical reasons). The multidimensional speech assessments will be blinded and completed and well-defined training programs will be used. The primary outcome measures are: acoustic intonation parameters, gender perception by listeners and self-assessment and client satisfaction. Linear mixed models with post-hoc pairwise comparisons will be used to analyze the evolution of continuous data within and between groups. ICC models and Cohen's kappa will be used to analyze inter- and intra rater reliability.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date October 26, 2026
Est. primary completion date October 26, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Normal hearing (using ISO standard audiometry) - Native Dutch speaker Exclusion Criteria: - A history of neurological disorders - Previous phonosurgery or speech therapy - Vocal pathology (using videolaryngostroboscopy) - Smokers.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intonation training
The participants will receive intonation training (1h/week) for four weeks, aiming for more gender congruent intonation patterns.
Sham therapy + intonation training
The participants will first receive four weeks of sham therapy (with no expected effect on speech), during which information on voice functioning, voice surgery, voice hygiene, and transgender health care will be provided. In addition, during sham therapy, active intervention will be given around nonverbal communication. After four weeks of sham therapy, for ethical reasons, subjects in this group will also receive four weeks of intonation training (aiming for more gender congruent intonation patterns).

Locations

Country Name City State
Belgium Ghent University Ghent East Flanders

Sponsors (1)

Lead Sponsor Collaborator
University Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in general intonation shift (Hz and ERB) The general intonation shift is the mean size of the general increase or decrease of the fundamental frequency during the utterance. For the calculation of this parameter, the first and last vowel of the sentence were selected and the fo of the vowels were determined. Subsequently, the general intonation shift was calculated as the difference between start and end fo. Based on the size of this difference, the general intonation shift was categorized as an upward, downward or flat intonation shift. A difference smaller than 1.570884399 ERB was considered as a flat intonation shift. Finally, the percentage of upward, downward and flat intonation shifts could be determined. baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
Primary Change in final intonation shift (Hz and ERB) The Final intonation shift indicates the average size of the upward or downward intonation shift at the end of the utterance. This parameter was calculated as the difference between the fo at the beginning of the final rise or drop and the fo at the end. The beginning was located on the last stressed vowel and the end of the final rise or drop was located on the last unstressed vowel. In case that the utterance ended with a stressed vowel, the intonation shift was derived from the difference in fo within this vowel. baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
Primary Change in general pitch range (Hz and ERB) This parameter was calculated as the difference between the minimum (5th percentile) and the maximum fo (95th percentile) of the utterance. For this calculation the "Intonantion and stress trajectory" script was used (Corthals, 2019a; Van Borsel, Vandaele, & Corthals, 2013). baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
Primary Change in pitch variation index (Hz/s and ERB/s) This parameter was determined by the sum of the absolute value of all pitch changes during the utterance between percentile 5 and 95 divided by the total duration of the utterance. The pitch variation index reflects the size and speed of the intonation maneuvers. For this parameter the script "Intonation and stress trajectory" was used (Corthals, 2019a; Van Borsel, Vandaele, & Corthals, 2013). baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
Primary Gender perception of the voice A listening experiment with femininity ratings using a visual analogue scale (VAS: very feminine - neutral - very masculine). During a listening experiment (+/- 40 minutes).
Primary Change in patient's satisfaction with their voice - VAS Visual analoge scales investigating the client's satisfaction of the therapy and psychosocial functioning:
examples:
My speech fits who I am (don't agree at all - neutral - completely agree)
How masculine/feminine do you sound while speaking? (very masculine - gender ambiguous (neutral) - very feminine)
While speaking, there is a wide variation of my pitch. (don't agree at all - neutral - completely agree) (3) I sound more feminine/male/neutral compared to before the training period. (don't agree at all - neutral - completely agree)
After the training period, my pitch range increased (I can produce higher and/or lower tones). (don't agree at all - neutral - completely agree))
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
Primary Change in patient's satisfaction with their voice - TWVQ Trans Women Voice Questionnaire: 30 questions investigating trans women's experiences with their voice (1 = never or seldom; 2 = sometimes; 3 = often; 4 = usual or always). The score can range from 30 to 120. A lower score indicates higher satisfaction with the voice. baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
Primary Change in patient's satisfaction with their voice - VHI Voice Handicap Index: 30 questions investigating the impact of voice on the quality of life (0 = never; 1 = almost never; 2 = sometimes; 3 = almost always; 4 = always) . The score can range from 30 to 120. A lower score indicates higher satisfaction with the voice. baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
Secondary Change in speech fundamental frequency (SFF) median speech fundamental frequency (SFF) baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
Secondary Change in formant frequency 1 (F1) F1 of the vowels /a/, /i/ and /u/ baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
Secondary Change in formant frequency 2 (F2) F2 of the vowels /a/, /i/ and /u/ baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
Secondary Change in formant frequency 3 (F3) F3 of the vowels /a/, /i/ and /u/ baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
Secondary Change in formant frequency 4 (F4) F4 of the vowels /a/, /i/ and /u/ baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
Secondary Change in formant frequency 5 (F5) F5 of the vowels /a/, /i/ and /u/ baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
See also
  Status Clinical Trial Phase
Recruiting NCT06098781 - Gynaecological Gender-affirming Surgeries
Recruiting NCT04064671 - ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery
Completed NCT03602222 - An LGBT-Competency Program for Mental Health Professionals in Romania N/A
Completed NCT04708600 - Effectiveness of Speech Therapy in Trans Women. N/A
Completed NCT04195659 - Chest Dysphoria in Transmasculine Spectrum Adolescents
Not yet recruiting NCT05903911 - Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria N/A
Not yet recruiting NCT04265885 - Gender Dysphoria and Transition
Not yet recruiting NCT04160364 - Gender Dysphoria in Children and Adolescents : Parents' Perspectives
Recruiting NCT06245681 - Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
Active, not recruiting NCT05489159 - Sleep and IR in Transgender Adolescents
Recruiting NCT04736797 - Transition in Transgender
Recruiting NCT04979338 - Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries Phase 3
Recruiting NCT05829928 - Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
Recruiting NCT04993469 - Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery N/A
Recruiting NCT05884307 - Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria N/A
Recruiting NCT05883553 - Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. N/A
Completed NCT04290286 - i2TransHealth: Interdisciplinary, Internet-based Trans Health Care N/A
Terminated NCT03078829 - The Relation of GnRH Treatment to QTc Interval in Transgender Females
Recruiting NCT05649605 - Early Mental Response - The EMRE Study N/A
Recruiting NCT06291675 - Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content